The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blinatumomab use in pediatric patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL) from an open-label, multicenter, expanded access study.
 
Franco Locatelli
No Relationships to Disclose
 
Gerhard Zugmaier
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Ajay Vora
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals; Pfizer
 
Claudia Rossig
Honoraria - Amgen; Pfizer; Roche
Consulting or Advisory Role - Roche
 
Christina Peters
Speakers' Bureau - Amgen; Jazz Pharmaceuticals; Medac; Neovii; Pfizer
Research Funding - Amgen (Inst); Jazz Pharmaceuticals (Inst); Medac (Inst); Neovii (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Jazz Pharmaceuticals; Medac; Neovii; Pfizer
 
Benoit Brethon
Travel, Accommodations, Expenses - Amgen
 
Maureen Megan O'Brien
Consulting or Advisory Role - Amgen
Research Funding - Amgen (Inst); Celgene (Inst); Epizyme (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene
 
Laura Belton
Employment - Amgen
 
Rupert Handgretinger
Consulting or Advisory Role - Amgen; Roche
Travel, Accommodations, Expenses - Amgen; Miltenyi Biotec; Roche